As one of the serious public health problems in China, chronic obstructive pulmonary disease (COPD) is the key prevention and control disease in the "Healthy China 2030" action plan, and the prevention and control situation is extremely grim. At the National People's Congress in recent years, many deputies have submitted suggestions on the prevention and treatment of COPD. In 2022, the National Health and Health Commission put chronic obstructive pulmonary disease into the reserve, and pressed the acceleration button for the inclusion of chronic obstructive pulmonary disease in the national basic public health service project.
"Chronic respiratory diseases are one of the four chronic diseases that seriously affect the health of Chinese residents." During the two sessions, Wu Hao, a CPPCC member and dean of the School of General Practice and Continuing Education of Capital Medical University, brought a proposal. He suggested that chronic respiratory diseases such as chronic obstructive pulmonary disease and asthma should be taken as the core, and respiratory infectious diseases such as influenza and COVID-19 should be taken as the benchmark to establish a first-class respiratory disease area.
At the same time, in response to the "Healthy China Action (20 19-2030)", China has conducted in-depth exploration and practice in the public health management of chronic obstructive pulmonary disease. Beijing, Ningxia, Shandong, Jiangsu, Henan, Sichuan and other places have carried out pilot projects for the prevention and treatment of chronic obstructive pulmonary disease. Through peer-to-peer training in primary medical institutions, a three-level prevention and treatment center for COPD was established, the Internet and medical health were fully integrated, and various measures such as "hospital-community-family" closed-loop management of COPD were realized.